Invesaro

Stocks TZOO Financial statements

Financial statements

TRAVELZOO financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TRAVELZOO files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue11410711110553.662.770.684.583.991.7
Cost of revenue13.912.912.311.410.611.41010.910.518.1
Gross profit10093.699.193.54351.360.673.573.473.6
Research and development9.19.228.996.713.082.592.062.112.412.55
Selling and marketing58.457.358.551.330.630.333.137.834.545.3
General and administrative22.722.623.318.420.519.817.918.118.118.9
Operating expenses90.289.190.876.457.152.6535854.966.7
Operating income10.24.558.2417-14.1-1.317.5615.618.56.9
Interest expense0.03
Other non-operating income-0.190.170.05-0.040.464.012.41.540.590.75
Pre-tax income104.728.2917-13.62.699.9617.119.17.66
Income tax3.993.133.634.71-2.441.783.275.115.42.68
Income from continuing operations6.011.594.6612.3-100.926.6911.913.64.7
Net income to minority interests0-1.15-0.01-0.010.10.120.28
Net income6.633.534.664.16-13.40.916.6312.413.64.7
EBITDA12.76.6210.118.4-11.80.519.7517.519.47.21
EPS, basic0.470.270.380.35-1.180.080.540.831.080.42
EPS, diluted0.470.270.370.35-1.180.070.530.831.060.41
Shares, basic (weighted)1412.912.311.811.311.612.414.912.611.2
Shares, diluted (weighted)1412.912.51211.31312.61512.911.5

Balance sheet

FY2016FY2017FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents26.822.61818.763.143.818.715.717.110
Receivables14.411.812.611.24.5214.913.81312.810.7
Inventory00.12
Other current assets0.440.280.170.070.090.080.140.090.140.09
Total current assets44.537.233.236.17065.135.630.831.823.4
Property, plant and equipment6.164.923.792.861.350.660.660.580.420.23
Lease right-of-use assets8.148.547.77.446.025.664.05
Goodwill010.910.910.910.910.910.9
Intangible assets04.533.433.652.091.51.45
Long-term investments02.692.480
Total assets53.545.743.454.510299.767.355.454.745.2
Accounts payable19.719.117.16.3873.414.274.556.167.76
Accrued liabilities8.78.77.856.288.6510.25.053.663.43.93
Deferred revenue0.720.831.340.792.691.732.222.046.558.73
Total current liabilities29.829.626.83582.987.947.534.236.534.2
Long-term debt00.810
Lease liabilities7.9210.89.118.336.725.654.18
Other non-current liabilities0.441.092.360.990.910.380
Total liabilities35.532.629.443.795.999.458.446.550.447.6
Paid-in capital00006.244.4223.30.4400
Retained earnings21.716.618.214.2-0.40.517.1419.514.37.24
Treasury stock0-5.49-7.130
Other comprehensive income-3.79-3.6-4.21-3.45-4.06-3.79-4.91-4.61-5.33-5.33
Shareholders' equity18.113.114.110.91.89-4.234.264.19-0.46-7.52
Minority interests04.614.64.64.74.825.09
Total equity18.113.114.110.91.89-4.238.858.884.35-2.42
Total liabilities and equity53.545.743.454.510299.767.355.454.745.2
Shares outstanding13.512.51211.511.412.115.713.611.810.9

Cash flow statement

FY2016FY2017FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income6.633.534.664.16-14.60.96.6312.513.74.98
Depreciation and amortization2.532.081.831.322.311.822.191.890.910.31
Stock-based compensation0.931.010.920.996.23.751.811.571.651.45
Deferred income tax-0.20.04-0.420.26-4.770.810.770.05-0.52-0.56
Change in receivables1.313.07-1.52-0.736.2-9.741.321.09-0.152.37
Cash from operations8.722.085.3211.247-8.08-23.110.721.15.66
Capital expenditures-0.91-0.74-0.75-0.47-0.25-0.03-0.46-0.26-0.18-0.07
Acquisitions0.0600
Sales and maturities of investments00.1300.220
Cash from investing-0.912.15-3.69-1.152.070.1-1.32-0.04-0.18-0.07
Stock issued01.710.0601.010
Share buybacks-9.66-9.71-5.29-10.8-1.21-5.49-1.64-16.8-18.9-13
Cash from financing-15.3-9.71-5.29-9.11-6.98-11.21.28-14.2-19-13.1
Exchange rate effect-0.881.25-0.880.271.57-0.26-2.460.53-0.60.5
Net change in cash-8.33-4.24-4.541.2543.7-19.4-25.6-2.991.35-6.98
Free cash flow7.811.344.5710.846.8-8.11-23.610.420.95.6
Interest paid0.090000.1400
Income taxes paid3.316.24.284.721.953.121.15-01.943.84

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $5.58 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin77.1%Gross profit / revenue.
Operating margin1.9%Operating income / revenue.
EBITDA margin2.1%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin2.1%Pre-tax income / revenue.
Net margin0.5%Net income / revenue.
FCF margin3.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin3.5%Cash from operations / revenue.
Effective tax rate67.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)1.0%Net income / average total assets.
R&D / revenue2.7%Research and development expense / revenue.
Stock-based pay / revenue1.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.0%Capital expenditures / revenue.
D&A / revenue0.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y9.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y9.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y0.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y6.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-62.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-3.0%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y-62.8%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-9.6%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y-65.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-10.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y-61.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-8.2%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y-73.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y-34.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-73.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-34.6%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-17.4%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-12.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-15.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-10.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.64xCurrent assets / current liabilities.
Quick ratio0.54x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.17x(Cash + short-term investments) / current liabilities.
Liabilities / assets113.8%Total liabilities / total assets.
Working capital-$14.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets25.9%(Goodwill + intangible assets) / total assets.
Tangible book value-$24.1MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.93xRevenue / average total assets.
Fixed asset turnover698xRevenue / average property, plant and equipment.
Receivables turnover6.34xRevenue / average receivables.
Days sales outstanding58 days365 x average receivables / revenue.
Days payables142 days365 x average accounts payable / cost of revenue.
FCF conversion682.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.05Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$8.93Revenue / diluted weighted shares.
FCF per share$0.31Free cash flow / diluted weighted shares.
Operating cash flow per share$0.32Cash from operations / diluted weighted shares.
Book value per share-$1.15Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$2.36Tangible book value / shares outstanding.
Cash per share$0.67(Cash + short-term investments) / shares outstanding.
Buybacks / FCF209.7%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$56.9MShare price x shares outstanding.
Enterprise value$50.1MMarket cap + total debt - cash - short-term investments.
P/E121xMarket cap / net income. Only when net income is positive.
P/S0.62xMarket cap / revenue.
P/FCF17.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF17.4xMarket cap / cash from operations, when positive.
EV/Sales0.54xEnterprise value / revenue.
EV/EBIT29.1xEnterprise value / operating income, when both are positive.
EV/EBITDA25.6xEnterprise value / EBITDA, when both are positive.
EV/FCF15.6xEnterprise value / free cash flow, when both are positive.
FCF yield5.7%Free cash flow / market cap.
Earnings yield0.8%Net income / market cap (the inverse of P/E).
Shareholder yield11.9%(Dividends paid + share buybacks) / market cap.
What was TRAVELZOO's revenue in fiscal 2025?

TRAVELZOO reported revenue of $91.7M for fiscal 2025, 9.3% higher than the year before.

Was TRAVELZOO profitable in fiscal 2025?

Yes. Net income was $4.7M, a net margin of 5.1%.

How much free cash flow did TRAVELZOO generate in fiscal 2025?

Cash from operations of $5.7M minus capital expenditures of $65.0K left free cash flow of $5.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TRAVELZOO